Opinion | Amgen Seeks to Monopolize Nature March 26, 2023 FacebookTwitterTelegramWhatsApp Opinion Commentary The Supreme Courtroom takes up an overbroad patent that seeks to pre-empt a competitor’s pharmaceutical product.
